Spain· ES:1221704006
LIVMARLI 30 MG COMPRIMIDOS
A medicinal product containing maralixibat, registered in Spain by Mirum Pharmaceuticals International B.V..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- maralixibat
- Manufacturer
- Mirum Pharmaceuticals International B.V.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- July 20, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Maralixibat in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaLIVMARLIMirum Pharmaceuticals International B.V., Amsterdam
- FinlandLivmarliMirum Pharmaceuticals International B.V.
- United KingdomLivmarli 30mg tabletsMirum Pharmaceuticals International BV
- IrelandLivmarli 30 mg tabletsMirum Pharmaceuticals International B.V.
- IcelandLivmarliMirum Pharmaceuticals International B.V.
- SwedenLivmarli 30 mg TablettMirum Pharmaceuticals International B.V.
- United StatesLivmarliMirum Pharmaceuticals Inc.
- BelgiumLivmarli 10 mgMirum Pharmaceuticals International
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Livmarli
- Liechtenstein · Livmarli
- Norway · Livmarli
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/413f49e3-b678-409b-b307-010a8fb5b5cb GET /v1/drugs/413f49e3-b678-409b-b307-010a8fb5b5cb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1784031433000}",
"nregistro": "1221704006",
"substance": "maralixibat"
}See everything about maralixibat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.